IL95061A0 - Antagonists of gm-csf derived from the carboxyl terminus - Google Patents

Antagonists of gm-csf derived from the carboxyl terminus

Info

Publication number
IL95061A0
IL95061A0 IL95061A IL9506190A IL95061A0 IL 95061 A0 IL95061 A0 IL 95061A0 IL 95061 A IL95061 A IL 95061A IL 9506190 A IL9506190 A IL 9506190A IL 95061 A0 IL95061 A0 IL 95061A0
Authority
IL
Israel
Prior art keywords
antagonists
carboxyl terminus
csf derived
csf
derived
Prior art date
Application number
IL95061A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL95061A0 publication Critical patent/IL95061A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243—Colony Stimulating Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
IL95061A 1989-07-14 1990-07-12 Antagonists of gm-csf derived from the carboxyl terminus IL95061A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37984689A 1989-07-14 1989-07-14

Publications (1)

Publication Number Publication Date
IL95061A0 true IL95061A0 (en) 1991-06-10

Family

ID=23498958

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95061A IL95061A0 (en) 1989-07-14 1990-07-12 Antagonists of gm-csf derived from the carboxyl terminus

Country Status (16)

Country Link
US (1) US5475087A (hu)
EP (2) EP0482086A1 (hu)
JP (1) JPH04503815A (hu)
KR (1) KR920701246A (hu)
AU (1) AU630496B2 (hu)
CA (1) CA2062975A1 (hu)
FI (1) FI920150A0 (hu)
HU (1) HUT63181A (hu)
IE (1) IE902562A1 (hu)
IL (1) IL95061A0 (hu)
MY (1) MY105946A (hu)
NO (1) NO920176L (hu)
NZ (1) NZ234479A (hu)
PH (1) PH27534A (hu)
WO (1) WO1991001330A1 (hu)
ZA (1) ZA905480B (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2060741A1 (en) * 1991-02-11 1992-08-12 Robert S. Greenfield Gm-csf inhibiting oligopeptides
WO1994011404A1 (en) * 1992-11-19 1994-05-26 Dana-Farber Cancer Institute Antibodies for gm-csf receptor and uses thereof
DK96493D0 (da) * 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
FR2730154B1 (fr) * 1995-02-08 1997-07-11 Stephanois Rech Dispositif de mesure des efforts exerces lors de la marche
AUPN378095A0 (en) 1995-06-23 1995-07-20 Bresagen Limited Haemopoietic growth factor antagonists and uses therefor
US7455836B2 (en) * 2000-05-08 2008-11-25 The University Of Melbourne Method of treatment and agents useful for same
US8062637B2 (en) * 2000-05-08 2011-11-22 Morphosys Ag Methods of ameliorating inflammatory disease using an uPA antagonist
US7247618B2 (en) * 2001-04-30 2007-07-24 Tripathi Rajavashisth Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling
AR045563A1 (es) 2003-09-10 2005-11-02 Warner Lambert Co Anticuerpos dirigidos a m-csf
EP1712241A1 (en) 2005-04-15 2006-10-18 Centre National De La Recherche Scientifique (Cnrs) Composition for treating cancer adapted for intra-tumoral administration and uses thereof
AU2005100402B4 (en) * 2005-05-16 2006-01-12 Novomatic Ag Method for increased chances at an award on a Gaming Machine
KR101486183B1 (ko) 2006-02-08 2015-01-28 모르포테크, 인크. 항원성 ｇｍ-ｃｓｆ 펩티드 및 ｇｍ-ｃｓｆ에 대한 항체
AU2013201228B2 (en) * 2006-02-08 2016-01-21 Eisai, Inc. Antigenic gm-csf peptides and antibodies to gm-csf
EP2402013A1 (en) * 2006-11-21 2012-01-04 Kalobios Pharmaceuticals, Inc. Methods of Treating Chronic Inflammatory Diseases using a GM-CSF Antagonist
US8398972B2 (en) 2006-11-21 2013-03-19 Kalobios Pharmaceuticals, Inc. Methods of treating dementia using a GM-CSF antagonist
TW200918553A (en) * 2007-09-18 2009-05-01 Amgen Inc Human GM-CSF antigen binding proteins
KR20100102108A (ko) 2007-11-13 2010-09-20 에베크 인코포레이티드 ｈＧＭ-ＣＳＦ에 결합하는 모노클로날 항체 및 이를 포함하는 의약 조성물
AU2009329811B2 (en) * 2008-12-22 2016-02-25 The University Of Melbourne Pain treatment
WO2010071924A1 (en) 2008-12-22 2010-07-01 The University Of Melbourne Osteoarthritis treatment
US9901079B2 (en) 2011-08-18 2018-02-27 New York University Inhibition of oncogenic kras-induced GM-CSF production and function
KR20140103122A (ko) * 2011-11-17 2014-08-25 넨키 인스티튜트 오브 익스페리멘탈 바이올로지 신경교종을 치료하기 위한 조성물 및 방법
EP4291380A1 (en) 2021-02-15 2023-12-20 Splifar S.A. Method for applying a seal to a plate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63224A (en) * 1980-07-17 1985-05-31 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
UA39161C2 (uk) * 1984-07-06 2001-06-15 Новартіс Аг Рекомбінантний білок gm-csf для збільшення продукції гранулоцитів і макрофагів у пацієнтів, вектор і кднк, що його кодують
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene

Also Published As

Publication number Publication date
HU9200087D0 (en) 1992-04-28
PH27534A (en) 1993-08-18
HUT63181A (en) 1993-07-28
EP0409091A1 (en) 1991-01-23
NO920176D0 (no) 1992-01-14
US5475087A (en) 1995-12-12
NO920176L (no) 1992-01-14
AU630496B2 (en) 1992-10-29
KR920701246A (ko) 1992-08-11
MY105946A (en) 1995-02-28
FI920150A0 (fi) 1992-01-14
IE902562A1 (en) 1991-02-27
WO1991001330A1 (en) 1991-02-07
EP0482086A1 (en) 1992-04-29
AU6148790A (en) 1991-02-22
CA2062975A1 (en) 1991-01-15
NZ234479A (en) 1992-03-26
JPH04503815A (ja) 1992-07-09
ZA905480B (en) 1991-03-27

Similar Documents

Publication Publication Date Title
IL95061A0 (en) Antagonists of gm-csf derived from the carboxyl terminus
ZA882421B (en) Leukotriene antagonists
EP0417959A3 (en) An assembly for locating the position of an object
PH21284A (en) Gnrh antagonists vi
IL65211A0 (en) Polypeptide antagonists arginine vasopressin
EP0502099A4 (en) Chimeric proteins
AU569064B2 (en) Leukotriene antagonists
ZW1784A1 (en) Gnrh antagonists
PL285188A1 (en) Ultrasonic probe
EP0421439A3 (en) Ultrasonic atomiser
AU591459B2 (en) cDNA probe for the detection of bluetongue virus
EP0418863A3 (en) Nmda antagonists
JPS6466174A (en) Leukotriene antagonist
GB8924829D0 (en) Object tracking
GB8923750D0 (en) Sonobuoy location
ZA907896B (en) Substituted acrylamido-penicillanic esters
ZA905205B (en) Theunis christiaan verster the location of objects
IE871656L (en) Leukotriene antagonists
GB8907660D0 (en) Polypeptide
IE852104L (en) GnRH ANTAGONISTS VI
BG47918A1 (en) Isolated analogous signal adapter
ZA887993B (en) The tracking of objects
IE894106L (en) Expression of the plasmodium circumsporozite protein in¹insects
ZA907310B (en) Nmda antagonists
IE871356L (en) Polypeptide compositions